MS
CERE

Maven Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Maven Securities’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 584
2024
Q2 		– Hold
0
– – – 565
2024
Q1 		– Hold
0
– – – 578
2023
Q4 		– Hold
0
– – – 611
2021
Q2 		– Sell
-8,299
Closed -$114K – 1063
2021
Q1 		$114K Buy
+8,299
New +$114K 0.01% 614